| # | Drug | Count |
|---|---|---|
| 0 | SIMVASTATIN | 13 |
| 1 | METFORMIN | 12 |
| 2 | METFORMIN ER 500 MG | 12 |
| 3 | METFORMIN ER 750 MG | 12 |
| 4 | TADALAFIL | 12 |
| 5 | VALSARTAN | 12 |
| 6 | VALSARTAN ORAL | 12 |
| 7 | LAMIVUDINE | 8 |
| 8 | LAMIVUDINE ORAL | 8 |
| 9 | RITONAVIR | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DORAVIRINE | 3 | 0.0038 |
| 1 | BESIFLOXACIN | 1 | 0.0010 |
| 2 | DARUNAVIR 600 MG | 5 | 0.0008 |
| 3 | RILPIVIRINE | 5 | 0.0007 |
| 4 | ZIDOVUDINE | 7 | 0.0007 |
| 5 | DESFLURANE | 1 | 0.0006 |
| 6 | RALTEGRAVIR | 3 | 0.0006 |
| 7 | NEVIRAPINE | 5 | 0.0006 |
| 8 | RITONAVIR 100 MG | 8 | 0.0005 |
| 9 | EFAVIRENZ | 5 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 8 | 0.0003 |
| 1 | Protease Inhibitor [EPC] | 8 | 0.0002 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 8 | 0.0002 |
| 3 | Cytochrome P450 3A Inhibitor [EPC] | 8 | 0.0001 |
| 4 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 2 | 0.0001 |
| 5 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 6 | Phosphodiesterase 5 Inhibitor [EPC] | 12 | 0.0001 |
| 7 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 8 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 8 | 0.0001 |
| 9 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |